A client develops severe diarrhea, mucositis, neutropenia, and neurotoxicity during the first treatment cycle of capecitabine. Which action is the priority?

1 Reassure the client that first-cycle toxicity is expected.
2 Give the next dose with an antidiarrheal drug.
3 Hold capecitabine and notify the oncology team urgently about possible severe fluoropyrimidine toxicity or DPD deficiency. ✓ Correct answer
4 Wait until the next scheduled cycle review.

Explanation

Acute early-onset or unusually severe toxicity can indicate complete or near-complete dihydropyrimidine dehydrogenase deficiency. Further exposure can be fatal and requires immediate interruption and evaluation.

Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
Treat early multisystem capecitabine toxicity as a stop signal.

Why this is correct
Supportive treatment does not make continued fluoropyrimidine exposure safe while severe toxicity is being evaluated.

Easy analogy or mental picture
Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.

Memory hook
Drug, urgent cue, protective action, and reassessment endpoint.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.

Why the other choices are wrong
Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.

References

1DailyMed: Capecitabine TabletsDPD deficiency and early severe or fatal fluoropyrimidine toxicity

Clinical scenario

Medication-safety review
Verify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

App Store Google Play

Read in another language: English 한국어 日本語繁體中文 Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.

성장을 멈추지 마세요

A client develops severe diarrhea, mucositis, neutropenia, and neurotoxicity during the first treatment cycle of capecitabine. Which action is the priority?

In-depth explanation

Clinical scenario

Master the NCLEX-RN with MyMerci